Cargando…

Characterization of the immune microenvironment in brain metastases from different solid tumors

BACKGROUND: Brain metastases are one of the most common intracranial neoplasms. Increasing evidence have indicated that systemic immunotherapy may provide long‐term benefits for brain metastases. Herein, we presented the results of an immune oncology panel RNA sequencing platform for patients with b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jinling, Wu, Lihong, Yuan, Fei, Ji, Jun, Lin, Xiaojing, Yang, Wanning, Wu, Junwei, Shi, Min, Yang, Hui, Ma, Yanna, Song, Xue, Zhu, Zhenggang, Zhang, Henghui, Zhang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131856/ https://www.ncbi.nlm.nih.gov/pubmed/32017467 http://dx.doi.org/10.1002/cam4.2905

Ejemplares similares

Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases
por: Zhou, Yuan, et al.
Publicado: (2021)

The microenvironment of brain metastases from solid tumors
por: Srinivasan, Ethan S, et al.
Publicado: (2021)

Midlife brain metastases in the United States: Is male at risk?
por: Che, Wenqiang, et al.
Publicado: (2022)

Genetic differences between lung metastases and liver metastases from left-sided microsatellite stable colorectal cancer: next generation sequencing and clinical implications
por: Wang, Zhenghang, et al.
Publicado: (2021)

Cancer‐associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases
por: Brown, Kai M., et al.
Publicado: (2021)

Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
por: Deng, Jia-Yi, et al.
Publicado: (2023)

Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)
por: Li, Meichen, et al.
Publicado: (2022)

Development and validation of risk and prognostic nomograms for bone metastases in Chinese advanced colorectal cancer patients
por: Wang, Nan, et al.
Publicado: (2021)

Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis
por: Wu, Xiangkun, et al.
Publicado: (2023)

Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes
por: Lou, Jiaying, et al.
Publicado: (2021)

Risk factors for brain metastases in patients with non–small‐cell lung cancer
por: An, Ning, et al.
Publicado: (2018)

Effects of somatic alterations at pathway level are more mechanism‐explanatory and clinically applicable to quantity of liver metastases of colorectal cancer
por: Zhang, Zhong‐guo, et al.
Publicado: (2019)

Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis
por: Liu, Hong, et al.
Publicado: (2019)

Genomic landscape of the immune microenvironments of brain metastases in breast cancer
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases
por: Schlam, Ilana, et al.
Publicado: (2022)

Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy
por: Jiang, Jinling, et al.
Publicado: (2019)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
por: Shi, Min, et al.
Publicado: (2020)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015)

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States
por: Arellano, Jorge, et al.
Publicado: (2015)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma
por: Zhang, Guo-Feng, et al.
Publicado: (2020)

Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods
por: Li, Xiao, et al.
Publicado: (2019)

Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer
por: Zhang, Libin, et al.
Publicado: (2021)

The role of DOT1L in the proliferation and prognosis of gastric cancer
por: Song, Zaozhi, et al.
Publicado: (2020)

A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience
por: McKee, Megan J., et al.
Publicado: (2016)

Development and validation of a nomogram to predict synchronous lung metastases in patients with ovarian cancer: a large cohort study
por: Yuan, Yufei, et al.
Publicado: (2020)

OTME-17. Single cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases
por: Smalley, Inna, et al.
Publicado: (2021)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

Data mining of immune-related prognostic genes in metastatic melanoma microenvironment
por: Han, Wei, et al.
Publicado: (2020)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
por: Trembath, Dimitri G., et al.
Publicado: (2021)

Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases
por: Yang, Jing, et al.
Publicado: (2016)

Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
por: Wang, Chao, et al.
Publicado: (2021)

The predictive value of serum lipids for eye metastases in male nasopharyngeal carcinoma patients
por: Xie, Zhen, et al.
Publicado: (2020)

Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression
por: Kolesnikoff, Natasha, et al.
Publicado: (2022)

The progress of microenvironment-targeted therapies in brain metastases
por: Long, Lifu, et al.
Publicado: (2023)

AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
por: Wu, Xiaoliang, et al.
Publicado: (2017)

EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients
por: Villalva, Claire, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tsdkufkjeogm4l9d6qg8t7oeuv